What is PRA Health Sciences Price-to-Free-Cash-Flow?
As of today (2024-05-12), PRA Health Sciences's share price is $165.21.
PRA Health Sciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2021 was $7.56. Hence, PRA Health Sciences's Price-to-Free-Cash-Flow Ratio for today is 21.86.
The historical rank and industry rank for PRA Health Sciences's Price-to-Free-Cash-Flow or its related term are showing as below:
PRAH'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 15.53 Med: 29.32 Max: 250.53
Current: 22.25
During the past 9 years, PRA Health Sciences's highest Price-to-Free-Cash-Flow Ratio was 250.53. The lowest was 15.53. And the median was 29.32.
PRAH's Price-to-Free-Cash-Flow is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 26.82
vs PRAH: 22.25
During the past 12 months, the average Free Cash Flow per Share Growth Rate of PRA Health Sciences was 126.10% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 30.80% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 19.50% per year.
During the past 9 years, PRA Health Sciences's highest 3-Year average Free Cash Flow per Share Growth Rate was 197.40% per year. The lowest was 9.40% per year. And the median was 29.30% per year.
PRA Health Sciences Price-to-Free-Cash-Flow Historical Data
The historical data trend for PRA Health Sciences's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PRA Health Sciences's Price-to-Free-Cash-Flow
For the Diagnostics & Research subindustry, PRA Health Sciences's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PRA Health Sciences's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PRA Health Sciences's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where PRA Health Sciences's Price-to-Free-Cash-Flow falls into.
PRA Health Sciences Price-to-Free-Cash-Flow Calculation
PRA Health Sciences's Price-to-Free-Cash-Flow ratio for today is calculated as
PRA Health Sciences's Share Price of today is $165.21. PRA Health Sciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.56.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PRA Health Sciences (NAS:PRAH) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
PRA Health Sciences Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of PRA Health Sciences's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
PRA Health Sciences (PRA Health Sciences) Business Description
PRA Health Sciences is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology firms. Its services run from early- to late-stage clinical trial outsourcing with varying levels of support, including one-off specialized staffing services to strategic partnerships where PRA handles nearly all aspects of the trial. In 2017, PRA acquired Symphony Health, a healthcare data and analytics provider. PRA's competitor, Icon, announced it will acquire PRA for $12 billion, which is scheduled to close in third-quarter 2021.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRAH has been successfully added to your 